Literature DB >> 20974336

Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.

Chung-Han Hsin1, Tsai-Hsin Chen, Yi-Ho Young, Wen-Shan Liu.   

Abstract

OBJECTIVE: To investigate the otologic complications in patients with nasopharyngeal carcinoma (NPC) who were treated by intensity-modulated radiotherapy (IMRT) and compared with those who were treated by two-dimensional radiotherapy (2DRT). STUDY
DESIGN: A historical cohort study was performed comprising NPC patients who underwent IMRT or 2DRT at Chung Shan Medical University Hospital.
SETTING: Chung Shan Medical University Hospital. SUBJECTS AND METHODS: Twenty-six NPC patients treated by IMRT (group A) and 18 NPC patients treated by 2DRT (group B) were enrolled. All patients underwent otoscopy, audiometry, and a vestibular-evoked myogenic potential (VEMP) test at a mean interval of three years after irradiation.
RESULTS: Although groups A and B did not significantly differ in the occurrence rate of otitis media with effusion (OME), group B had a significantly greater occurrence rate of chronic otitis media than group A (P < 0.05, χ(2) test). The incidences of high-frequency sensorineural hearing loss were 46 percent in group A and 67 percent in group B, with no significant difference between the two. In terms of VEMPs, group A had a significantly lower abnormal rate (31%) than group B (61%; P < 0.05, χ(2) test). In addition, a significant relationship existed between T stages and OME in NPC patients treated by IMRT (P < 0.01, Fisher-Freeman-Halton test) but not by 2DRT.
CONCLUSION: The incidence of chronic otitis media and abnormal VEMPs in NPC patients treated by IMRT were significantly lower when compared with those treated by 2DRT, demonstrating the superiority of IMRT in decreasing unwanted otologic complications. However, occurrence of OME, which was related with advanced T stage, cannot be reduced by IMRT.
Copyright © 2010 American Academy of Otolaryngology–Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20974336     DOI: 10.1016/j.otohns.2010.07.012

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.

Authors:  Chung-Han Hsin; Hsien-Chun Tseng; Huang-Pin Lin; Tsai-Hsin Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

2.  Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?

Authors:  Ayca Ant; Ömer Yazici; Pinar Atabey; Ferit Ferhat Aslan; Arzubetul Duran; Samet Ozlugedik; Yusuf Kemal Kemaloglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-22       Impact factor: 2.503

3.  Adverse Cochlear Effects After Head and Neck Cancer Therapy.

Authors:  Vanita Sarin
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-30

4.  The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion.

Authors:  Paninee Charusripan; Likhit Khattiyawittayakun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-24       Impact factor: 2.503

5.  Factors influencing the incidence of sinusitis in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy.

Authors:  Yan-xia Su; Lan-ping Liu; Lei Li; Xu Li; Xiu-juan Cao; Wei Dong; Xin-hua Yang; Jin Xu; Shui Yu; Jun-fang Hao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12       Impact factor: 2.503

6.  Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Authors:  Jie Deng; Barbara A Murphy; Mary S Dietrich; Nancy Wells; Kenneth A Wallston; Robert J Sinard; Anthony J Cmelak; Jill Gilbert; Sheila H Ridner
Journal:  Head Neck       Date:  2012-07-12       Impact factor: 3.147

7.  Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma.

Authors:  Jin Wang; Yuan-Yuan Chen; An Tai; Xue-Lin Chen; Shao-Ming Huang; Cungen Yang; Yong Bao; Ning-Wei Li; Xiao-Wu Deng; Chong Zhao; Ming Chen; X Allen Li
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

8.  Effect of Hydrogen Inhalation Therapy on Hearing Loss of Patients With Nasopharyngeal Carcinoma After Radiotherapy.

Authors:  Xiaofeng Kong; Tianyu Lu; You-Yong Lu; Zhinan Yin; Kecheng Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.